The Family Firm’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,691
| Closed | -$684K | – | 131 |
|
2025
Q1 | $684K | Sell |
9,691
-363
| -4% | -$25.6K | 0.15% | 95 |
|
2024
Q4 | $661K | Buy |
10,054
+31
| +0.3% | +$2.04K | 0.15% | 94 |
|
2024
Q3 | $708K | Buy |
10,023
+51
| +0.5% | +$3.6K | 0.15% | 98 |
|
2024
Q2 | $661K | Buy |
9,972
+44
| +0.4% | +$2.92K | 0.15% | 94 |
|
2024
Q1 | $674K | Sell |
9,928
-410
| -4% | -$27.8K | 0.16% | 92 |
|
2023
Q4 | $639K | Buy |
10,338
+333
| +3% | +$20.6K | 0.16% | 91 |
|
2023
Q3 | $590K | Sell |
10,005
-414
| -4% | -$24.4K | 0.17% | 91 |
|
2023
Q2 | $622K | Sell |
10,419
-468
| -4% | -$27.9K | 0.16% | 93 |
|
2023
Q1 | $636K | Buy |
10,887
+492
| +5% | +$28.7K | 0.18% | 89 |
|
2022
Q4 | $645K | Sell |
10,395
-1,179
| -10% | -$73.2K | 0.19% | 92 |
|
2022
Q3 | $654K | Sell |
11,574
-165
| -1% | -$9.32K | 0.21% | 84 |
|
2022
Q2 | $750K | Sell |
11,739
-285
| -2% | -$18.2K | 0.22% | 79 |
|
2022
Q1 | $779K | Sell |
12,024
-2,283
| -16% | -$148K | 0.2% | 81 |
|
2021
Q4 | $952K | Buy |
14,307
+57
| +0.4% | +$3.79K | 0.25% | 73 |
|
2021
Q3 | $885K | Buy |
14,250
+2,133
| +18% | +$132K | 0.23% | 75 |
|
2021
Q2 | $750K | Buy |
12,117
+585
| +5% | +$36.2K | 0.2% | 80 |
|
2021
Q1 | $683K | Buy |
11,532
+3
| +0% | +$178 | 0.2% | 76 |
|
2020
Q4 | $706K | Sell |
11,529
-333
| -3% | -$20.4K | 0.21% | 75 |
|
2020
Q3 | $647K | Buy |
11,862
+54
| +0.5% | +$2.95K | 0.23% | 72 |
|
2020
Q2 | $606K | Buy |
11,808
+1,194
| +11% | +$61.3K | 0.23% | 71 |
|
2020
Q1 | $476K | Hold |
10,614
| – | – | 0.2% | 74 |
|
2019
Q4 | $567K | Sell |
10,614
-135
| -1% | -$7.21K | 0.19% | 75 |
|
2019
Q3 | $501K | Buy |
10,749
+2,535
| +31% | +$118K | 0.18% | 83 |
|
2019
Q2 | $413K | Buy |
8,214
+1,095
| +15% | +$55.1K | 0.15% | 91 |
|
2019
Q1 | $365K | Buy |
7,119
+1,278
| +22% | +$65.5K | 0.13% | 97 |
|
2018
Q4 | $274K | Buy |
5,841
+27
| +0.5% | +$1.27K | 0.11% | 109 |
|
2018
Q3 | $325K | Buy |
5,814
+216
| +4% | +$12.1K | 0.12% | 106 |
|
2018
Q2 | $282K | Sell |
5,598
-1,647
| -23% | -$83K | 0.11% | 105 |
|
2018
Q1 | $356K | Buy |
7,245
+1,974
| +37% | +$97K | 0.14% | 95 |
|
2017
Q4 | $271K | Buy |
+5,271
| New | +$271K | 0.11% | 109 |
|